43 min listen
Shockwave (SWAV) Receives Buyout Offer from J&J: What Investors Should Know
Shockwave (SWAV) Receives Buyout Offer from J&J: What Investors Should Know
ratings:
Length:
13 minutes
Released:
Apr 5, 2024
Format:
Podcast episode
Description
ShockWave Medical (Nasdaq: SWAV), the innovative pioneer of intravascular lithotripsy, has received an all-cash acquisition offer from Johnson & Johnson (NYSE: JNJ) for $335 per share. In today's episode, 7investing advisors Luke Hallard and Simon Erickson discuss why we made ShockWave a 7investing recommendation, several financial details of the offer, and what investors should expect going forward.
---
Send in a voice message: https://podcasters.spotify.com/pod/show/7investing/message
---
Send in a voice message: https://podcasters.spotify.com/pod/show/7investing/message
Released:
Apr 5, 2024
Format:
Podcast episode
Titles in the series (100)
Has the Market Recovered Too Quickly? What Should Investors do Now? by The 7investing Podcast